Chau‐Ting Yeh - Publications, H-index & Citations

Chau‐Ting Yeh

chang gung memorial hospital

51H指数

390论文数

1.0W被引数

收录论文 172

发表时间

GALNT14 Genetic Variants Harbor Differential Prognostic Values Linking to Distinct Macrophage Cell Types in Hepatocellular Carcinoma GALNT14基因变异携带与不同巨噬细胞类型相关的差异性预后价值，在肝细胞癌中

Journal of Hepatocellular Carcinoma

IF3.4

2025-08-04

OAAI

Yu-De Chu; Pei-Huan Ho; Wei-Ting Chen; Yu-Lin Shih; Ming-Wei Lai; Chao-Wei Hsu; Chau-Ting Yeh

ANGPTL3 overcomes sorafenib resistance via suppression of SNAI1 and CPT1A in liver cancer ANGPTL3通过抑制SNAI1和CPT1A克服肝癌中的索拉非尼耐药性。

TRANSLATIONAL ONCOLOGY

IF4.1

2025-02-01

OAAI

Lin, Yang-Hsiang; Chen, Cheng-Yi; Chi, Hsiang-Cheng; Wu, Meng-Han; Lai, Ming-Wei; Yeh, Chau-Ting

Hepatitis C Virus NS5A Activates Mitophagy Through Cargo Receptor and Phagophore Formation

PATHOGENS

IF3.3

2024-12-23

OAAI

Hsiao, Yuan-Chao; Chang, Chih-Wei; Yeh, Chau-Ting; Ke, Po-Yuan

Cytidine deaminase enhances liver cancer invasion by modulating epithelial-mesenchymal transition via NFκB signaling 胞苷脱氨酶通过NFκB信号通路调控上皮-间质转化，增强肝癌侵袭。

Biomedical Journal

IF4.4

2024-09-19

OAAI

Chia-Jung Liao; Yang-Hsiang Lin; Huei-Tzu Chien; Yi-Wen Wang; Tzu-Kang Lin; Chau-Ting Yeh; Kwang-Huei Lin

High expression of embryonic stem cell marker SSEA3 confers poor prognosis and promotes epithelial mesenchymal transition in hepatocellular carcinoma 胚胎干细胞标记物SSEA3的高表达赋予肝细胞癌不良预后并促进上皮间质转化

BIOMEDICAL JOURNAL

IF4.4

2024-04-01

OAAI

Hung, Tsai-Hsien; Huang, Yenlin; Yeh, Chau-Ting; Yeh, Chun-Nan; Yu, John; Lin, Chun-Cheng; Chiou, Shih-Pin; Chiang, Pei-Yun; Hung, Jung-Tung; Yu, Alice L.

Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients

CLINICAL AND MOLECULAR HEPATOLOGY

IF16.9

2024-04-01

OAAI

Hou, Jinlin; Gane, Edward; Balabanska, Rozalina; Zhang, Wenhong; Zhang, Jiming; Lim, Tien Huey; Xie, Qing; Yeh, Chau-Ting; Yang, Sheng-Shun; Liang, Xieer; Komolmit, Piyawat; Leerapun, Apinya; Xue, Zenghui; Chen, Ethan; Zhang, Yuchen; Xie, Qiaoqiao; Chang, Ting-Tsung; Hu, Tsung-Hui; Lim, Seng Gee; Chuang, Wan -Long; Leggett, Barbara; Bo, Qingyan; Zhou, Xue; Triyatni, Miriam; Zhang, Wen; Yuen, Man-Fung

Keratin X promotes cell metastasis and sorafenib resistance via the AMPK α/Snail axis in hepatocellular carcinoma

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Lin, Yang-Hsiang; Yeh, Chau-Ting

Preventing viral relapse with prophylactic tenofovir in hepatitis B carriers receiving chemotherapy: a phase IV randomized study in Taiwan

HEPATOLOGY INTERNATIONAL

IF6.1

2024-02-20

OAAI

Hsu, Chao-Wei; Chen, Shin-Cheh; Wang, Po-Nan; Wang, Hung-Ming; Chen, Yi-Cheng; Yeh, Chau-Ting

Deciphering hepatoma cell resistance to tyrosine kinase inhibitors: insights from a Liver-on-a-Chip model unveiling tumor endothelial cell mechanisms ( vol 24 ,pg 3668 ,2024)

LAB ON A CHIP

IF5.4

2024-01-01

OAAI

Poddar, Madhu Shree; Chu, Yu-De; Yeh, Chau-Ting; Liu, Cheng-Hsien

Exploring cancer-associated fibroblast-induced resistance to tyrosine kinase inhibitors in hepatoma cells using a liver-on-a-chip model

LAB ON A CHIP

IF5.4

2024-01-01

PREAI

Poddar, Madhu Shree; Chu, Yu-De; Pendharkar, Gaurav; Liu, Cheng-Hsien; Yeh, Chau-Ting

Deciphering hepatoma cell resistance to tyrosine kinase inhibitors: insights from a Liver-on-a-Chip model unveiling tumor endothelial cell mechanisms

LAB ON A CHIP

IF5.4

2024-01-01

PREAI

Poddar, Madhu Shree; Chu, Yu-De; Yeh, Chau-Ting; Liu, Cheng-Hsien

Aldolase B-driven lactagenesis and CEACAM6 activation promote cell renewal and chemoresistance in colorectal cancer through the Warburg effect

CELL DEATH & DISEASE

IF9.6

2023-10-10

OAAI

Chu, Yu-De; Cheng, Li-Chun; Lim, Siew-Na; Lai, Ming-Wei; Yeh, Chau-Ting; Lin, Wey-Ran

Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer

CELLS

IF5.2

2023-03-10

OAAI

Huang, Po-Shuan; Wang, Ling-Yu; Wang, Yi-Wen; Tsai, Ming-Ming; Lin, Tzu-Kang; Liao, Chia-Jung; Yeh, Chau-Ting; Lin, Kwang-Huei

Mifepristone inhibits hepatoma growth by enhancing the GR-HSP60-survivin interaction to facilitate survivin degradation

JOURNAL OF CANCER

IF3.2

2023-01-01

OAAI

Huang, Ya-Hui; Lin, Kwang-Huei; Lai, Ming-Wei; Yeh, Chau-Ting

WWOX-rs13338697 genotype predicts therapeutic efficacy of ADI-PEG 20 for patients with advanced hepatocellular carcinoma

FRONTIERS IN ONCOLOGY

IF3.3

2022-12-02

OAAI

Chu, Yu-De; Liu, Hui-Fen; Chen, Yi-Chen; Chou, Chun-Hung; Yeh, Chau-Ting

GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells

CELL DEATH & DISEASE

IF9.6

2022-11-14

OAAI

Chu, Yu-De; Fan, Tan-Chi; Lai, Ming-Wei; Yeh, Chau-Ting

Bone Densities Assessed by Hounsfield Units at L5 in Computed Tomography Image Independently Predict Hepatocellular Carcinoma Development in Cirrhotic Patients

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-09-22

OAAI

Yeh, Christopher; Lai, Ming-Wei; Yeh, Chau-Ting; Lin, Yang-Hsiang; Tseng, Jeng-Hwei

CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance

CLINICAL EPIGENETICS

IF4.4

2022-08-23

OAAI

Liu, Yu-Chin; Lin, Yang-Hsiang; Chi, Hsiang-Cheng; Huang, Po-Shuan; Liao, Chia-Jung; Liou, Yu-Syuan; Lin, Chiao-Chun; Yu, Chia-Jung; Yeh, Chau-Ting; Huang, Ya-Hui; Lin, Kwang-Huei

LPAL2 Suppresses Tumor Growth and Metastasis of Hepatocellular Carcinoma by Modulating MMP9 Expression LPAL2通过调节MMP9表达抑制肝细胞癌的生长和转移

CELLS

IF5.2

2022-08-22

OAAI

Lin, Yang-Hsiang; Liu, Yu-Chin; Chen, Cheng-Yi; Chi, Hsiang-Cheng; Wu, Meng-Han; Huang, Po-Shuan; Chang, Cheng-Chih; Lin, Tzu-Kang; Yeh, Chau-Ting; Lin, Kwang-Huei

Drosophila CTP synthase regulates collective cell migration by controlling the polarized endocytic cycle

DEVELOPMENT

IF3.6

2022-08-22

OAAI

Wang, Pei-Yu; Chakraborty, Archan; Ma, Hsin-Ju; Wu, Jhen-Wei; Jang, Anna C-C; Lin, Wei-Cheng; Pi, Hai-Wei; Yeh, Chau-Ting; Cheng, Mei-Ling; Yu, Jau-Song; Pai, Li-Mei

研究方向